CD20 Protein Expression and Anti CD 20 Therapy in Lymphoma Cancer
978-613-9-83213-2
6139832136
60
2018-05-14
38.77 $
eng
https://images.our-assets.com/cover/230x230/9786139832132.jpg
https://images.our-assets.com/fullcover/230x230/9786139832132.jpg
https://images.our-assets.com/cover/2000x/9786139832132.jpg
https://images.our-assets.com/fullcover/2000x/9786139832132.jpg
Book focus to determine the CD20 protein expression in B-cell lymphoma cancer. The aim and objective are as follows: To study the incidence of CD20 in B-cell lymphoma. To evaluate expression of CD20 protein on paraffin embedded tissue sections by Immunohistochemical analysis in B-cell lymphoma. Immunohistochemical analysis is advantageous because the antigen expression can be studied within the cancer cells. To correlate CD20 expression with established clinico-pathological parameters, and understanding antiCD20 therapy on B-cell lymphoma patients. It was assumed that data from the present study would provide better insight in to the role of CD20 in B-cell lymphoma patients, and further help in treatment planning of these patients.
https://morebooks.de/books/es/published_by/lap-lambert-academic-publishing/47/products
Farmacia
https://morebooks.de/store/es/book/cd20-protein-expression-and-anti-cd-20-therapy-in-lymphoma-cancer/isbn/978-613-9-83213-2